Envestnet Portfolio Solutions, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Envestnet Portfolio Solutions, Inc.
- $24.4 Billion
- Q2 2025
A detailed history of Envestnet Portfolio Solutions, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Portfolio Solutions, Inc. holds 2,169 shares of REGN stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,169
Previous 1,771
22.47%
Holding current value
$1.21 Million
Previous $1.12 Million
1.34%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,425Shares Held
85.2MCall Options Held
1.39MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.27 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.73 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.17 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.68 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$2.23 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $60B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...